Literature DB >> 1654541

Exercise-induced urinary excretion of leukotriene E4 in children with atopic asthma.

Y Kikawa1, S Hosoi, Y Inoue, M Saito, A Nakai, Y Shigematsu, T Hirao, M Sudo.   

Abstract

Urinary levels of leukotriene (LT) E4, a stable end-product of LTC4 and LTD4, were measured before and after exercise in 10 children with severe asthma and seven children with moderate asthma using HPLC and RIA to clarify the relationship of LT to the severity of asthma and to the degree of bronchospasm in exercise-induced asthma. The urinary LTE4 level significantly increased after exercise in the severe asthma group, but not in the moderate asthma group (14.3 +/- 14.5 to 24.3 +/- 20.6 versus 19.6 +/- 12.3 to 17.6 +/- 10.8 ng/mmol creatinine, p less than 0.05). The urinary LTE4 level increased in 10 patients (eight with severe asthma), and it decreased in seven patients (five with moderate asthma). A significant difference in the degree of bronchospasm after exercise (as shown by the maximal % fall in the peak expiratory flow rate), was seen when patients with increased urinary LTE4 excretion were compared with those with decreased excretion (60.4 +/- 17.3 versus 24.1 +/- 14.3%, p less than 0.01). Our findings suggest that exercise-induced asthma, or at least a subtype of exercise-induced asthma, may partly develop through the release of LTC4.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654541     DOI: 10.1203/00006450-199105010-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.

Authors:  K W Rundell; B A Spiering; J M Baumann; T M Evans
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

2.  Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.

Authors:  T F Reiss; J B Hill; E Harman; J Zhang; W K Tanaka; E Bronsky; D Guerreiro; L Hendeles
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

3.  Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors.

Authors:  P Tagari; C Brideau; C Chan; R Frenette; C Black; A Ford-Hutchinson
Journal:  Agents Actions       Date:  1993-09

4.  A framework for in vitro systems toxicology assessment of e-liquids.

Authors:  Anita R Iskandar; Ignacio Gonzalez-Suarez; Shoaib Majeed; Diego Marescotti; Alain Sewer; Yang Xiang; Patrice Leroy; Emmanuel Guedj; Carole Mathis; Jean-Pierre Schaller; Patrick Vanscheeuwijck; Stefan Frentzel; Florian Martin; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Toxicol Mech Methods       Date:  2016-04-26       Impact factor: 2.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.